1. Fig. 1. ILCs gating strategy use to describe ILC1s, ILC2s and ILC3s from peripheral blood. Representative flow cytometry dot plot demonstrating ILC gating strategy, ILC were defined as CD45+ Viable Lin−CD127+CD161+. ILCs were characterized into 3 groups based on CRTH2 and c-Kit, ILC1s (CRTH2−c-Kit−), ILC2s (CRTH2+), and ILC3s (CRTH2−c-Kit+). NKp44 in humans is used to gate ILC3s NCR+ (NKp44+) and ILC3s NCR− (NKp44−). ILC, innate lymphoid cell; NCR, natural cytotoxicity receptor.
Fig. 1. ILCs gating strategy use to describe ILC1s, ILC2s and ILC3s from peripheral blood. Representative flow cytometry dot plot demonstrating ILC gating strategy, ILC were defined as CD45+ Viable Lin−CD127+CD161+. ILCs were characterized into 3 groups based on CRTH2 and c-Kit, ILC1s (CRTH2−c-Kit−), ILC2s (CRTH2+), and ILC3s (CRTH2−c-Kit+). NKp44…
Allergy Asthma Immunol Res Nov;10(6):